Article Versions Notes

Simón M, Jørgensen JT, Khare HA, Christensen C, Nielsen CH, Kjaer A. Combination of [¹⁷⁷Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model. Pharmaceutics. 2022; 14(6):1284. https://doi.org/10.3390/pharmaceutics14061284

Simón, Marina, Jesper Tranekjær Jørgensen, Harshvardhan A. Khare, Camilla Christensen, Carsten Haagen Nielsen, and Andreas Kjaer. 2022. "Combination of [¹⁷⁷Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model" Pharmaceutics 14, no. 6: 1284. https://doi.org/10.3390/pharmaceutics14061284

Simón, M., Jørgensen, J. T., Khare, H. A., Christensen, C., Nielsen, C. H., & Kjaer, A. (2022). Combination of [¹⁷⁷Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model. Pharmaceutics, 14(6), 1284. https://doi.org/10.3390/pharmaceutics14061284